Fingerprint
Dive into the research topics where Francia Reyes Silva is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
CD70-Targeting CAR NK Cells Overcome BCMA Downregulation and Improve Survival in High-risk Multiple Myeloma Models
Lin, P., Acharya, S., Reyes-Silva, F., Basar, R., Uprety, N., Moreno Rueda, L. Y., Lin, P., Gilbert, A. L., Banerjee, P. P., Fang, D., Zhang, C., Nunez Cortes, A. K., Melo Garcia, L., Daher, M., Muniz-Feliciano, L., Deyter, G. M., Woods, V., Rawal, S., Li, P. & Jones, C. M. & 9 others, , Mar 4 2026, In: Blood Cancer Discovery. 7, 2, p. 234-249 16 p.Research output: Contribution to journal › Article › peer-review
Open Access3 Link opens in a new tab Scopus citations -
Role of BK Virus CTLs in the Treatment of BK Virus–Associated Nephropathy in Kidney-Transplant and Hematopoietic Cell Transplant Recipients
Olson, A., Li, Y. E., Basar, R., Banerjee, P., Kaur, I., Abueg, G., Sylejmani, M., Uprety, N., Shrestha, R., Silva, F. R., Page, V., Champlin, R. E., Kontoyiannis, D. P., Chemaly, R. F., Shpall, E. J., Moore, L., Gaber, O. A., Rezvani, K. & Abudayyeh, A., Mar 1 2026, In: Transplant Infectious Disease. 28, 2, e70178.Research output: Contribution to journal › Article › peer-review
Open Access -
Allogeneic NK cells with a bispecific innate cell engager in refractory relapsed lymphoma: a phase 1 trial
Nieto, Y., Banerjee, P., Kaur, I., Basar, R., Li, Y., Daher, M., Rafei, H., Kerbauy, L. N., Kaplan, M., Marin, D., Griffin, L., Barnett, M., Bassett, R., Uprety, N., Shrestha, R., Silva, F. R., Islam, S., Ganesh, C., Borneo, Z. & Ramdial, J. & 16 others, , Jun 2025, In: Nature medicine. 31, 6, p. 1987-1993 7 p.Research output: Contribution to journal › Article › peer-review
39 Link opens in a new tab Scopus citations -
Correction to: Allogeneic NK cells with a bispecific innate cell engager in refractory relapsed lymphoma: a phase 1 trial (Nature Medicine, (2025), 31, 6, (1987-1993), 10.1038/s41591-025-03640-8)
Nieto, Y., Banerjee, P., Kaur, I., Basar, R., Li, Y., Daher, M., Rafei, H., Kerbauy, L. N., Kaplan, M., Marin, D., Griffin, L., Barnett, M., Bassett, R., Uprety, N., Shrestha, R., Silva, F. R., Islam, S., Ganesh, C., Borneo, Z. & Ramdial, J. & 16 others, , Aug 2025, In: Nature medicine. 31, 8, p. 2816 1 p.Research output: Contribution to journal › Comment/debate › peer-review
Open Access1 Link opens in a new tab Scopus citations -
CREM is a regulatory checkpoint of CAR and IL-15 signalling in NK cells
Rafei, H., Basar, R., Acharya, S., Hsu, Y. S., Liu, P., Zhang, D., Bohn, T., Liang, Q., Mohanty, V., Upadhyay, R., Li, P., Phadatare, P., Dede, M., Xiong, D., Fan, H., Jones, C. M., Kunz, S., Daher, M., Nunez Cortes, A. K. & Shanley, M. & 38 others, , Jul 24 2025, In: Nature. 643, 8073, p. 1076-1086 11 p.Research output: Contribution to journal › Article › peer-review
Open Access32 Link opens in a new tab Scopus citations